JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$2.29B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.1B |
| 3 |
Vanguard Total International Bond ETF
BNDX
|
+$1.67B |
| 4 |
AbbVie
ABBV
|
+$1.6B |
| 5 |
ExxonMobil
XOM
|
+$1.5B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$3.99B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.33B |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$1.15B |
| 4 |
Tesla
TSLA
|
+$1.05B |
| 5 |
iShares TIPS Bond ETF
TIP
|
+$1.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.67% |
| 2 | Technology | 16.04% |
| 3 | Healthcare | 10.96% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Philip Morris
PM
$312B
| $2.37B | 0.29% |
25,222,352
+1,807,425
| +8% | +$181M |
2013 Q2
35 quarters
|
|
77
Northrop Grumman
NOC
$68.2B
| $2.34B | 0.28% |
5,241,906
-181,037
| -3% | -$74.7M |
2013 Q2
35 quarters
|
|
78
Intuit
INTU
$82.6B
| $2.33B | 0.28% |
4,853,848
+320,676
| +7% | +$164M |
2013 Q2
35 quarters
|
|
79
Booking.com
BKNG
$120B
| $2.31B | 0.28% |
24,595,250
-1,470,350
| -6% | -$137M |
2013 Q2
35 quarters
|
|
80
CALL
iShares S&P 100 ETF
OEF
$20.8B
| $2.29B | 0.28% |
23,566,200
-7,361,000
| -24% | -$1.51B |
2014 Q3
30 quarters
|
|
81
Lam Research
LRCX
$407B
| $2.28B | 0.27% |
42,364,230
-1,124,420
| -3% | -$65.5M |
2013 Q2
35 quarters
|
|
82
PepsiCo
PEP
$172B
| $2.26B | 0.27% |
13,512,015
-1,864,085
| -12% | -$313M |
2013 Q2
35 quarters
|
|
83
Centene
CNC
$32.6B
| $2.25B | 0.27% |
26,720,429
+3,334,745
| +14% | +$274M |
2013 Q2
35 quarters
|
|
84
Intuitive Surgical
ISRG
$149B
| $2.23B | 0.27% |
7,401,516
+1,422,984
| +24% | +$416M |
2013 Q2
35 quarters
|
|
85
Xcel Energy
XEL
$45.9B
| $2.18B | 0.26% |
30,240,516
-1,143,542
| -4% | -$78.6M |
2013 Q2
35 quarters
|
|
86
State Street Health Care Select Sector SPDR ETF
XLV
$43.5B
| $2.14B | 0.26% |
15,656,545
-1,648,982
| -10% | -$218M |
2013 Q2
35 quarters
|
|
87
Visa
V
$711B
| $2.14B | 0.26% |
9,661,779
+2,195,269
| +29% | +$475M |
2013 Q2
35 quarters
|
|
88
Boston Scientific
BSX
$61.1B
| $2.12B | 0.25% |
47,771,662
+956,611
| +2% | +$41.5M |
2013 Q2
35 quarters
|
|
89
Accenture
ACN
$126B
| $2.11B | 0.25% |
6,260,088
+285,170
| +5% | +$96.2M |
2013 Q2
35 quarters
|
|
90
Blackrock
BLK
$166B
| $2.1B | 0.25% |
2,754,343
+346,358
| +14% | +$271M |
2013 Q2
35 quarters
|
|
91
Medtronic
MDT
$113B
| $2.09B | 0.25% |
18,860,634
-433,883
| -2% | -$45.8M |
2013 Q2
35 quarters
|
|
|
92
Vanguard Short-Term Treasury ETF
VGSH
$34.5B
| $2.09B | 0.25% |
35,265,192
-19,058,579
| -35% | -$1.15B |
2018 Q3
14 quarters
|
|
93
HDFC Bank
HDB
$114B
| $2.09B | 0.25% |
68,113,928
-2,430,692
| -3% | -$79M |
2013 Q2
35 quarters
|
|
94
PNC Financial Services
PNC
$87.2B
| $2.08B | 0.25% |
11,270,188
-1,296,179
| -10% | -$262M |
2013 Q2
35 quarters
|
|
95
PUT
iShares Morningstar Value ETF
ILCV
$1.34B
| $2.07B | 0.25% |
24,987,600
+9,520,300
| +62% | +$646M |
2014 Q3
30 quarters
|
|
96
iShares Russell 1000 Growth ETF
IWF
$130B
| $2.06B | 0.25% |
29,671,588
-1,947,460
| -6% | -$133M |
2013 Q2
35 quarters
|
|
97
PPG Industries
PPG
$23.3B
| $2.01B | 0.24% |
15,347,437
-2,218,264
| -13% | -$322M |
2013 Q2
35 quarters
|
|
98
Verizon
VZ
$178B
| $2B | 0.24% |
39,211,058
+5,451,684
| +16% | +$289M |
2013 Q2
35 quarters
|
|
99
Mondelez International
MDLZ
$77.2B
| $1.98B | 0.24% |
31,526,970
+3,645,078
| +13% | +$237M |
2013 Q2
35 quarters
|
|
100
Mercado Libre
MELI
$94.5B
| $1.97B | 0.24% |
1,658,446
-98,951
| -6% | -$108M |
2014 Q3
30 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2022 Portfolio in Review
As of Q1 2022, JP Morgan Chase held 7,378 positions worth $830B, down 4.1% from $866B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q1 2022 filing shows 606 new, 2,655 increased, 2,664 reduced and 677 closed positions. Its largest new stake was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M. The largest sale was Vanguard Short-Term Bond ETF, an estimated $3.99B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2022 buy was iShares AAA-A Rated Corporate Bond ETF: 4,681,132 shares worth $243M.
- JP Morgan Chase added most to Vanguard Total Bond Market in Q1 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q1 2022 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $3.99B.
- JP Morgan Chase fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $442M.
- JP Morgan Chase's ten largest holdings make up 18% of its $830B portfolio in Q1 2022.
- JP Morgan Chase opened 606 new positions and closed 677 in Q1 2022.
- JP Morgan Chase's portfolio value fell 4.1% quarter-over-quarter to $830B.
Based on JP Morgan Chase's 13F filing for Q1 2022, filed 11 May 2022.